Logo image of PSBD

PALMER SQUARE CAPITAL BDC IN (PSBD) Stock Fundamental Analysis

USA - NYSE:PSBD - US69702V1070 - Common Stock

12.2 USD
-0.14 (-1.13%)
Last: 10/10/2025, 6:30:00 PM
Fundamental Rating

3

PSBD gets a fundamental rating of 3 out of 10. The analysis compared the fundamentals against 238 industry peers in the Capital Markets industry. PSBD has a bad profitability rating. Also its financial health evaluation is rather negative. PSBD is not valued too expensively and it also shows a decent growth rate.


Dividend Valuation Growth Profitability Health

2

1. Profitability

1.1 Basic Checks

In the past year PSBD was profitable.
PSBD had a positive operating cash flow in the past year.
PSBD Yearly Net Income VS EBIT VS OCF VS FCFPSBD Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2021 2022 2023 2024 0 100M -100M -200M -300M -400M

1.2 Ratios

With a Return On Assets value of 1.39%, PSBD is not doing good in the industry: 63.45% of the companies in the same industry are doing better.
With a Return On Equity value of 3.61%, PSBD is not doing good in the industry: 67.23% of the companies in the same industry are doing better.
PSBD has a Return On Invested Capital of 3.57%. This is comparable to the rest of the industry: PSBD outperforms 47.48% of its industry peers.
The Average Return On Invested Capital over the past 3 years for PSBD is below the industry average of 7.64%.
Industry RankSector Rank
ROA 1.39%
ROE 3.61%
ROIC 3.57%
ROA(3y)1.97%
ROA(5y)N/A
ROE(3y)3.9%
ROE(5y)N/A
ROIC(3y)3.69%
ROIC(5y)N/A
PSBD Yearly ROA, ROE, ROICPSBD Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2021 2022 2023 2024 0 10 -10 20 -20

1.3 Margins

PSBD's Profit Margin of 13.51% is in line compared to the rest of the industry. PSBD outperforms 47.90% of its industry peers.
In the last couple of years the Profit Margin of PSBD has declined.
PSBD has a Operating Margin of 42.41%. This is in the better half of the industry: PSBD outperforms 73.53% of its industry peers.
PSBD's Operating Margin has declined in the last couple of years.
PSBD has a Gross Margin (46.00%) which is in line with its industry peers.
In the last couple of years the Gross Margin of PSBD has declined.
Industry RankSector Rank
OM 42.41%
PM (TTM) 13.51%
GM 46%
OM growth 3Y-8.82%
OM growth 5YN/A
PM growth 3Y-11.57%
PM growth 5YN/A
GM growth 3Y-9.03%
GM growth 5YN/A
PSBD Yearly Profit, Operating, Gross MarginsPSBD Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2021 2022 2023 2024 0 50 -50

2

2. Health

2.1 Basic Checks

Compared to 1 year ago, PSBD has about the same amount of shares outstanding.
PSBD has a better debt/assets ratio than last year.
PSBD Yearly Shares OutstandingPSBD Yearly Shares OutstandingYearly Shares Outstanding 2021 2022 2023 2024 10M 20M 30M
PSBD Yearly Total Debt VS Total AssetsPSBD Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2021 2022 2023 2024 500M 1B

2.2 Solvency

PSBD has an Altman-Z score of 0.41. This is a bad value and indicates that PSBD is not financially healthy and even has some risk of bankruptcy.
Looking at the Altman-Z score, with a value of 0.41, PSBD is doing worse than 65.13% of the companies in the same industry.
PSBD has a debt to FCF ratio of 6.10. This is a slightly negative value and a sign of low solvency as PSBD would need 6.10 years to pay back of all of its debts.
PSBD has a better Debt to FCF ratio (6.10) than 67.23% of its industry peers.
PSBD has a Debt/Equity ratio of 1.51. This is a high value indicating a heavy dependency on external financing.
The Debt to Equity ratio of PSBD (1.51) is worse than 72.27% of its industry peers.
Industry RankSector Rank
Debt/Equity 1.51
Debt/FCF 6.1
Altman-Z 0.41
ROIC/WACCN/A
WACCN/A
PSBD Yearly LT Debt VS Equity VS FCFPSBD Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2021 2022 2023 2024 0 200M -200M 400M -400M 600M 800M

2.3 Liquidity

PSBD has a Current Ratio of 0.55. This is a bad value and indicates that PSBD is not financially healthy enough and could expect problems in meeting its short term obligations.
PSBD has a worse Current ratio (0.55) than 75.63% of its industry peers.
A Quick Ratio of 0.55 indicates that PSBD may have some problems paying its short term obligations.
PSBD has a Quick ratio of 0.55. This is in the lower half of the industry: PSBD underperforms 75.21% of its industry peers.
Industry RankSector Rank
Current Ratio 0.55
Quick Ratio 0.55
PSBD Yearly Current Assets VS Current LiabilitesPSBD Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2021 2022 2023 2024 20M 40M 60M 80M 100M

4

3. Growth

3.1 Past

The earnings per share for PSBD have decreased strongly by -78.43% in the last year.
PSBD shows a strong growth in Earnings Per Share. Measured over the last years, the EPS has been growing by 36.02% yearly.
Looking at the last year, PSBD shows a small growth in Revenue. The Revenue has grown by 3.96% in the last year.
Measured over the past years, PSBD shows a very strong growth in Revenue. The Revenue has been growing by 53.49% on average per year.
EPS 1Y (TTM)-78.43%
EPS 3Y36.02%
EPS 5YN/A
EPS Q2Q%37.5%
Revenue 1Y (TTM)3.96%
Revenue growth 3Y53.49%
Revenue growth 5YN/A
Sales Q2Q%-13.33%

3.2 Future

PSBD is expected to show a small growth in Earnings Per Share. In the coming years, the EPS will grow by 0.89% yearly.
PSBD is expected to show a very negative growth in Revenue. In the coming years, the Revenue will decrease by -21.65% yearly.
EPS Next Y-46.46%
EPS Next 2Y3.7%
EPS Next 3Y0.89%
EPS Next 5YN/A
Revenue Next Year-15.11%
Revenue Next 2Y-10.54%
Revenue Next 3Y-21.65%
Revenue Next 5YN/A

3.3 Evolution

When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
The Revenue growth rate is decreasing: in the next years the growth will be less than in the last years.
PSBD Yearly Revenue VS EstimatesPSBD Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2021 2022 2023 2024 2025 2026 2027 50M 100M
PSBD Yearly EPS VS EstimatesPSBD Yearly EPS VS EstimatesYearly EPS VS Estimates 2023 2024 2025 2026 2027 0.5 1 1.5 2

4

4. Valuation

4.1 Price/Earnings Ratio

With a Price/Earnings ratio of 22.18, PSBD is valued on the expensive side.
60.08% of the companies in the same industry are cheaper than PSBD, based on the Price/Earnings ratio.
PSBD's Price/Earnings ratio indicates a similar valuation than the S&P500 average which is at 27.02.
A Price/Forward Earnings ratio of 7.72 indicates a rather cheap valuation of PSBD.
Based on the Price/Forward Earnings ratio, PSBD is valued cheaper than 83.19% of the companies in the same industry.
Compared to an average S&P500 Price/Forward Earnings ratio of 22.57, PSBD is valued rather cheaply.
Industry RankSector Rank
PE 22.18
Fwd PE 7.72
PSBD Price Earnings VS Forward Price EarningsPSBD Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 10 20 30 40 50

4.2 Price Multiples

Based on the Price/Free Cash Flow ratio, PSBD is valued cheaper than 86.55% of the companies in the same industry.
Industry RankSector Rank
P/FCF 3.13
EV/EBITDA N/A
PSBD Per share dataPSBD EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 5 10 15

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y3.7%
EPS Next 3Y0.89%

3

5. Dividend

5.1 Amount

With a Yearly Dividend Yield of 12.27%, PSBD is a good candidate for dividend investing.
Compared to an average industry Dividend Yield of 8.50, PSBD pays a bit more dividend than its industry peers.
Compared to an average S&P500 Dividend Yield of 2.44, PSBD pays a better dividend.
Industry RankSector Rank
Dividend Yield 12.27%

5.2 History

PSBD does not have a reliable dividend history as it only pays dividend since a couple or years.
Dividend Growth(5Y)N/A
Div Incr Years0
Div Non Decr Years0
PSBD Yearly Dividends per sharePSBD Yearly Dividends per shareYearly Dividends per share 2024 2025 0.5 1 1.5

5.3 Sustainability

323.12% of the earnings are spent on dividend by PSBD. This is not a sustainable payout ratio.
DP323.12%
EPS Next 2Y3.7%
EPS Next 3Y0.89%
PSBD Yearly Income VS Free CF VS DividendPSBD Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2021 2022 2023 2024 0 100M -100M -200M -300M -400M
PSBD Dividend Payout.PSBD Dividend Payout, showing the Payout Ratio.PSBD Dividend Payout.PayoutRetained Earnings

PALMER SQUARE CAPITAL BDC IN

NYSE:PSBD (10/10/2025, 6:30:00 PM)

12.2

-0.14 (-1.13%)

Chartmill FA Rating
GICS SectorFinancials
GICS IndustryGroupFinancial Services
GICS IndustryCapital Markets
Earnings (Last)08-06 2025-08-06/bmo
Earnings (Next)11-03 2025-11-03/bmo
Inst Owners69.32%
Inst Owner Change0%
Ins Owners0.81%
Ins Owner Change0%
Market Cap391.99M
Analysts75
Price Target14.59 (19.59%)
Short Float %0.08%
Short Ratio0.31
Dividend
Industry RankSector Rank
Dividend Yield 12.27%
Yearly Dividend1.43
Dividend Growth(5Y)N/A
DP323.12%
Div Incr Years0
Div Non Decr Years0
Ex-Date09-26 2025-09-26 (0.42)
Surprises & Revisions
EPS beat(2)0
Avg EPS beat(2)-110.32%
Min EPS beat(2)-178.67%
Max EPS beat(2)-41.97%
EPS beat(4)0
Avg EPS beat(4)-74.83%
Min EPS beat(4)-178.67%
Max EPS beat(4)-25.17%
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)1
Avg Revenue beat(2)-2.86%
Min Revenue beat(2)-6.77%
Max Revenue beat(2)1.04%
Revenue beat(4)2
Avg Revenue beat(4)-1.18%
Min Revenue beat(4)-6.77%
Max Revenue beat(4)2.94%
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)0.7%
EPS NQ rev (1m)1.24%
EPS NQ rev (3m)1.57%
EPS NY rev (1m)-8.5%
EPS NY rev (3m)-5.7%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)-3.82%
Revenue NY rev (1m)-1.22%
Revenue NY rev (3m)-1.01%
Valuation
Industry RankSector Rank
PE 22.18
Fwd PE 7.72
P/S 2.9
P/FCF 3.13
P/OCF 3.13
P/B 0.78
P/tB 0.78
EV/EBITDA N/A
EPS(TTM)0.55
EY4.51%
EPS(NY)1.58
Fwd EY12.96%
FCF(TTM)3.9
FCFY31.94%
OCF(TTM)3.9
OCFY31.94%
SpS4.2
BVpS15.72
TBVpS15.72
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA 1.39%
ROE 3.61%
ROCE 4.52%
ROIC 3.57%
ROICexc 3.61%
ROICexgc 3.61%
OM 42.41%
PM (TTM) 13.51%
GM 46%
FCFM 92.69%
ROA(3y)1.97%
ROA(5y)N/A
ROE(3y)3.9%
ROE(5y)N/A
ROIC(3y)3.69%
ROIC(5y)N/A
ROICexc(3y)3.7%
ROICexc(5y)N/A
ROICexgc(3y)3.7%
ROICexgc(5y)N/A
ROCE(3y)4.67%
ROCE(5y)N/A
ROICexcg growth 3Y31.14%
ROICexcg growth 5YN/A
ROICexc growth 3Y31.14%
ROICexc growth 5YN/A
OM growth 3Y-8.82%
OM growth 5YN/A
PM growth 3Y-11.57%
PM growth 5YN/A
GM growth 3Y-9.03%
GM growth 5YN/A
F-Score6
Asset Turnover0.1
Health
Industry RankSector Rank
Debt/Equity 1.51
Debt/FCF 6.1
Debt/EBITDA N/A
Cap/Depr N/A
Cap/Sales N/A
Interest Coverage 1.05
Cash Conversion N/A
Profit Quality 685.91%
Current Ratio 0.55
Quick Ratio 0.55
Altman-Z 0.41
F-Score6
WACCN/A
ROIC/WACCN/A
Cap/Depr(3y)N/A
Cap/Depr(5y)N/A
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-78.43%
EPS 3Y36.02%
EPS 5YN/A
EPS Q2Q%37.5%
EPS Next Y-46.46%
EPS Next 2Y3.7%
EPS Next 3Y0.89%
EPS Next 5YN/A
Revenue 1Y (TTM)3.96%
Revenue growth 3Y53.49%
Revenue growth 5YN/A
Sales Q2Q%-13.33%
Revenue Next Year-15.11%
Revenue Next 2Y-10.54%
Revenue Next 3Y-21.65%
Revenue Next 5YN/A
EBIT growth 1Y-8.02%
EBIT growth 3Y39.96%
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y-1126.42%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-1126.42%
OCF growth 3YN/A
OCF growth 5YN/A